文献速递生殖医学

显微外科输精管附睾吻合术治疗附睾梗阻性无精子症患者的妊娠率与活产率

Pregnancy and live birth rates after microsurgical vasoepididymostomy for azoospermic patients with epididymal obstruction.
PubMed 文献 · Hum Reprod · 2017-01-05

这项回顾性研究分析了2011年1月至2013年7月期间241例因附睾梗阻接受显微外科输精管附睾吻合术(MVE)的患者,其中198例(82.2%)数据纳入分析。术后总通畅率为76.3%,总妊娠率为40.9%(81/198),总活产率为34.8%。男性年龄、精子浓度和前向运动力是妊娠的预测因素。

要点

  • MVE治疗附睾梗阻性无精子症的总通畅率为76.3%,总活产率为34.8%。
  • 双侧吻合、远端吻合及附睾液中存在活动精子与通畅率升高相关。
  • 男性年龄(HR 0.407)、精子浓度(HR 4.988)和前向运动力(HR 1.751)是妊娠的预测因素。

核心结论

  • MVE是附睾梗阻性无精子症的有效治疗方法,总通畅率和活产率分别为76.3%和34.8%。
  • 精子浓度和前向运动力可能预测术后妊娠。
  • 显微外科重建可作为附睾梗阻的首选。

研究设计与样本

  • 回顾性研究,2011年1月至2013年7月在本男科中心因附睾梗阻接受MVE的241例患者,198例(82.2%)数据纳入分析。
  • 所有患者接受阴囊探查和MVE,术后每3个月分析精液直至妊娠。
  • 比较通畅组与非通畅组的术前和术中数据,采用Cox回归模型进行单因素和多因素分析以识别妊娠预测因素。

主要发现

  • 男性平均(±SD)年龄为31.0±5.8岁,女性伴侣为28.4±4.4岁。
  • 术后151例(76.3%)患者精液中存在精子。
  • 双侧吻合、远端吻合及附睾液中存在活动精子的患者通畅率升高。
  • 81/198例男性(40.9%)报告伴侣妊娠,73例新生儿分娩,总活产率为34.8%。
  • 男性年龄(HR 0.407 [95%CI 0.203-0.816],P=0.011)、精子浓度(HR 4.988 [95%CI 2.777-8.957],P<0.001)和前向运动力(HR 1.751 [95%CI 1.042-2.945],P=0.035)是妊娠的预测因素。

临床怎么用

  • MVE是附睾梗阻性无精子症的有效治疗方法。
  • 精子浓度和前向运动力可能预测术后妊娠。
  • 显微外科重建可作为附睾梗阻的首选。

局限性

  • 需要一项比较MVE与IVF/ICSI的妊娠率、活产率、风险和医疗费用的随机对照试验。
  • 年龄>35岁女性的样本量小,因此无法确定女性年龄是否为妊娠的预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can microsurgical vasoepididymostomy (MVE) be an effective treatment for azoospermic men with epididymal obstruction? SUMMARY ANSWER: MVE is an effective treatment for epididymal obstruction, with overall patency and live birth rates of 76.3% and 34.8%, respectively. WHAT IS KNOWN ALREADY: We showed that MVE was an effective treatment for non-vasectomized patients with epididymal obstruction and prior failed sperm retrieval for ICSI. ICSI is the preferred treatment for obstructive azoospermia in some reproductive centers. Some small studies documented that MVE could achieve high patency and pregnancy rates. STUDY DESIGN, SIZE, DURATION: This retrospective study was designed to investigate the natural pregnancy and live birth rates after MVE and to identify possible predictors of pregnancy. From January 2011 to July 2013, 241 patients underwent MVE for epididymal obstruction in our andrology center. PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients underwent scrotal exploration and MVE. Semen was analyzed every 3 months postoperatively until pregnancy was achieved. Patency, pregnancy and live birth rates were evaluated. Preoperative and intraoperative data were compared between patent and non-patent groups to identify factors affecting the patency rate. Predictors of pregnancy were identified by univariate and multivariate analyses with Cox regression models. MAIN RESULTS AND THE ROLE OF CHANCE: Data from 198 males (82.2%) were analyzed. The mean (±SD) age of males and female partners was 31.0 ± 5.8 and 28.4 ± 4.4 years, respectively. Sperm was present in the ejaculate of 151 patients (76.3%) postoperatively. Patency rates were increased for patients with bilateral anastomosis, distant anastomosis and motile sperm in epididymal fluid. Overall, 81/198 males (40.9%) reported pregnancy in partners and 73 newborns were delivered. The overall live birth rate was 34.8%. Male age (hazard ratio (HR) [95% CI] 0.407 [0.203-0.816], P = 0.011), sperm concentration (HR [95% CI] 4.988 [2.777-8.957], P < 0.001) and forward motility (HR [95% CI] 1.751 [1.042-2.945], P = 0.035) were predictors of pregnancy. LIMITATIONS, REASONS FOR CAUTION: A randomized control trial comparing pregnancy rates, live birth rates, risks and medical costs of MVE and IVF/ICSI is needed. The sample size of females >35 years old was small, so we could not determine whether female age was a predictor of pregnancy. WIDER IMPLICATIONS OF THE FINDINGS: MVE is an effective therapy for azoospermic patients with epididymal obstruction. Sperm concentration and forward motility may predict pregnancy after the procedure. Microsurgical reconstruction could be a first choice for epididymal obstruction. STUDY FUNDING/COMPETING INTERESTS: No external funding was received. The authors have no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Peng J, Zhang Z, Yuan Y, et al. Pregnancy and live birth rates after microsurgical vasoepididymostomy for azoospermic patients with epididymal obstruction. Hum Reprod. 2017. PMID: 28057874. doi:10.1093/humrep/dew331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。